2017
DOI: 10.1159/000479253
|View full text |Cite
|
Sign up to set email alerts
|

Uremia Retention Molecules and Clinical Outcomes

Abstract: Chronic kidney disease is characterized by the accumulation of organic compounds in the bloodstream that may exert a variety of toxic effects in the body. These compounds, collectively known as uremic toxins, may be classified according to their physicochemical properties as free water-soluble low molecular weight molecules, middle molecules or protein-bound uremic toxins. Most of these retention molecules, due to either their size and/or binding to protein, constitute a complex therapeutic challenge to the ne… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 49 publications
(55 reference statements)
0
9
0
Order By: Relevance
“…Elevated ADMA and SDMA are related with increased all-cause mortality and cardiovascular disease [ 39 ]. Both markers accumulate in chronic kidney disease by increased synthesis, reduced catabolism and reduced renal clearance [ 40 ]. They are small molecules (202 Da) but poorly dialyzed with a substantial rebound occurring at the end of dialysis, which is explained by extended volume of distribution [ 41 , 42 ].…”
Section: Discussionmentioning
confidence: 99%
“…Elevated ADMA and SDMA are related with increased all-cause mortality and cardiovascular disease [ 39 ]. Both markers accumulate in chronic kidney disease by increased synthesis, reduced catabolism and reduced renal clearance [ 40 ]. They are small molecules (202 Da) but poorly dialyzed with a substantial rebound occurring at the end of dialysis, which is explained by extended volume of distribution [ 41 , 42 ].…”
Section: Discussionmentioning
confidence: 99%
“…Such results are partly due to the ever-changing case mix with a continuous increase of older and sicker population. Nevertheless, we may recognize important limitations of current dialysis technology that appears to be incapable of achieving adequate blood purification from several identified uremic toxins [1-6, 34-36]. Continuous innovation and research are therefore needed to improve quality of care and to find solutions for unmet clinical needs [37, 38].…”
Section: Discussionmentioning
confidence: 99%
“…In a rat model of chronic renal failure (CRF), the overload of PAH and indoleacetic acid accelerated the loss of kidney function, glomerular sclerosis and tubulointerstitial injury [141]. Numerous studies in patients with CRF showed that uremic toxin accumulation leads to various complications including endothelial senescence [142], atherogenesis [143], cardiovascular diseases [144,145] or increased risk of all-cause mortality [144,146]. In CRF, these toxins accumulate for very long periods, making their toxicity particularly critical.…”
Section: Accumulation Of Toxic Substancesmentioning
confidence: 99%